Vitreomacular Traction: Causes, Symptoms, and Treatment
Schedule Today
Who Is at Risk for VMT
VMT is primarily an age-related condition, but certain health and eye factors can increase a person's likelihood of developing it. Knowing the risk factors can help with early detection and monitoring.
VMT is most common in adults over the age of 60. The vitreous changes that lead to incomplete separation are a natural part of aging. Women may face a higher risk than men, which some research links to post-menopausal changes in estrogen levels that may influence how the vitreous liquefies and separates.
Several eye-related conditions can raise the likelihood of developing VMT. These include conditions that alter the structure of the eye or affect the retina directly.
- Previous cataract surgery, which can change the environment inside the eye
- Myopia (nearsightedness), which alters the shape and structure of the eye
- Diabetic retinopathy, which affects the blood vessels of the retina
- Age-related macular degeneration, which weakens the macular tissue
- Retinal vein occlusion, which involves blocked blood flow in the retina
The use of pilocarpine, a medication sometimes prescribed for presbyopia (age-related difficulty focusing on near objects), has been identified as a potential contributing factor for VMT. VMT can occur in both eyes, though it more commonly affects one eye at a time. People with smaller areas of vitreous attachment to the macula may have a better chance of the condition resolving on its own, which is one reason our specialists carefully measure the adhesion size when planning care.
Recognizing the Symptoms of VMT
The symptoms of VMT are closely tied to changes in the macula, which controls central and fine-detail vision. Some people notice symptoms right away, while others may have no symptoms at all in early stages.
The most common symptom of VMT is metamorphopsia, which means straight lines appear wavy, bent, or irregular. Door frames, text, and grid patterns may look distorted. This happens because the pulling force on the macula warps its normally flat surface. Decreased visual acuity (blurred central vision), difficulty reading, and trouble recognizing faces are also frequent complaints. Some people experience micropsia, where objects appear smaller than they actually are.
Some people with VMT notice a sudden increase in floaters, which are small spots, strings, or cobweb-like shapes that drift across their field of vision. Flashes of light in the peripheral (side) vision can also occur as the vitreous tugs on the retina. It is important to note that these same symptoms can also be signs of a retinal tear or retinal detachment, which are serious and require immediate care.
If you experience a sudden increase in floaters, new flashes of light, or a shadow or curtain spreading across your vision, seek emergency evaluation right away.
In its earliest stage, VMT may cause no noticeable symptoms. The vitreous may be attached to the macula without yet exerting enough force to distort the tissue. This stage is often discovered incidentally during a routine eye exam or imaging study. Even without symptoms, a retina specialist may recommend periodic monitoring, since the condition can progress without warning.
Treatment Options for VMT
The right treatment for VMT depends on the severity of symptoms, the size of the vitreous attachment, and whether complications have developed. There are several approaches available, and our specialists will help determine which is most appropriate for each patient.
For many patients, the first approach is careful observation, sometimes called watchful waiting. A retina specialist monitors the condition with regular OCT imaging and eye exams. Spontaneous resolution of VMT, meaning the vitreous separates naturally on its own, occurs in a meaningful percentage of patients, particularly those with smaller focal adhesions under 1,500 micrometers, no epiretinal membrane, a natural lens still in place, and younger age at diagnosis. This option is most appropriate when symptoms are mild and stable.
Ocriplasmin (brand name Jetrea) is an injectable enzyme medication approved for the treatment of VMT. It is administered through an intravitreal injection, which means it is delivered directly into the eye after numbing drops are applied. Ocriplasmin works by dissolving the protein bonds that hold the vitreous to the macula, encouraging natural separation. This treatment tends to work best for patients with focal adhesions and no epiretinal membrane. Not every patient responds to the medication, and some may still need surgery. Temporary side effects can include floaters, blurred vision, and mild discomfort.
Pneumatic vitreolysis is a minimally invasive in-office procedure in which a small gas bubble is injected into the vitreous cavity. The bubble rises against the macula and helps the vitreous separate from the retinal surface. This approach has shown favorable results in carefully selected patients. Because it is a newer technique, it may not be suitable for everyone. A retina specialist will assess whether the specific characteristics of the traction make this option appropriate.
Pars plana vitrectomy is a surgical procedure in which the vitreous gel is removed from inside the eye through tiny incisions using specialized instruments. Removing the vitreous eliminates the source of traction entirely. This is considered the definitive treatment for VMT and has a high success rate for releasing traction and improving visual acuity. The removed vitreous is replaced with a saline solution or a gas bubble, and the eye gradually fills the space with its own natural fluid over time.
Choosing the most appropriate treatment involves weighing several factors together. These include the severity of symptoms, current level of visual acuity, the size and location of the vitreous adhesion, and whether complications such as a macular hole or epiretinal membrane are already present. Our retina specialists consider all of these factors along with a patient's overall eye health and medical history. In many cases, observation is tried first, and intervention is reserved for situations where symptoms worsen or complications develop.
What to Expect During and After Treatment
Understanding what the treatment process looks like can help reduce anxiety and support a smooth recovery. The experience varies depending on which treatment is recommended.
If observation is recommended, you will have regular follow-up appointments that include OCT imaging and vision testing. You may also be asked to monitor your vision at home using an Amsler grid. The observation period can last from several months to over a year. During this time, the traction may remain stable, worsen, or resolve on its own. It is important to report any new or changing symptoms between visits without waiting for your next scheduled appointment.
Intravitreal injections are performed in our office after numbing drops are applied to make the eye comfortable. Most patients return to normal daily activities within one to two days. Temporary side effects such as mild floaters, blurred vision, or brief discomfort are common in the first few days. Our team will schedule a follow-up visit to assess how well the treatment is working and whether further care is needed.
Vitrectomy is performed in an operating room, typically under local anesthesia with sedation. Recovery takes longer than from an injection, generally several weeks for the eye to heal. If a gas bubble is placed during surgery, you may be asked to maintain a specific head position for several days and will need to avoid air travel until the bubble fully absorbs. Vision improvement after surgery is often gradual and may continue over a period of weeks to months.
The long-term outlook for VMT depends on how early the condition is detected and whether complications have developed before treatment. Patients who receive timely care often experience meaningful improvement in vision. However, outcomes vary based on how long the traction was present and how much the macular tissue was affected. Some patients may have residual visual distortion even after successful treatment, particularly if the macula was significantly stretched or damaged. Consistent follow-up with a retina specialist is essential for monitoring recovery and watching for any new developments.
Living With Vitreomacular Traction
A VMT diagnosis can feel overwhelming, but there are practical steps you can take to protect your vision and manage daily life during monitoring or recovery.
Using an Amsler grid each day is one of the most practical things you can do when living with VMT. Check one eye at a time and note any areas where lines look wavy, broken, or missing. Good lighting makes close tasks easier if your central vision is affected. Magnifying devices and large-print materials can also be helpful. Wearing sunglasses with UV protection outdoors supports general eye health.
Changes in vision can be stressful and frustrating, and it is completely normal to feel anxious about the possibility of worsening symptoms or the prospect of surgery. Speaking openly with our team about your concerns can provide reassurance and help you feel more in control. For patients whose vision is significantly affected, low vision rehabilitation services are available. These programs offer tools, training, and strategies to support reading, cooking, technology use, and other daily activities.
Certain changes in vision should never be ignored or left until a routine appointment. Contact a retina specialist or seek emergency evaluation immediately if you notice any of the following.
- A sudden significant increase in floaters
- New flashes of light, especially in peripheral vision
- A curtain, shadow, or veil spreading across your field of vision
- Sudden loss of vision in one eye
- Rapid worsening of central distortion or blurring
These symptoms can signal that VMT is progressing quickly or that a more serious condition, such as a retinal detachment, has developed. Prompt evaluation is critical to protecting your vision.
Frequently Asked Questions
Here are answers to some of the questions we hear most often about VMT, including guidance to help you make informed decisions about your care.
Yes, spontaneous resolution is possible, particularly in patients with smaller focal adhesions under 1,500 micrometers and no epiretinal membrane. However, the likelihood depends on the specific characteristics of your condition, not all VMT cases resolve without intervention. Our specialists use OCT imaging over time to determine whether natural separation is occurring. If symptoms are worsening or structural complications are developing, waiting too long may limit how well vision can recover.
Gradual, stable blurring or mild line distortion that you have already discussed with your specialist can generally wait for your next scheduled appointment, as long as nothing changes. However, a sudden dramatic increase in floaters, new flashes of light, a shadow across your vision, or any rapid loss of vision should be evaluated the same day. These symptoms can indicate a retinal tear or detachment, which are time-sensitive emergencies that can result in permanent vision loss if not treated promptly.
The key difference is whether the vitreous attachment is actively distorting or damaging the macular tissue. Adhesion means the vitreous is attached but not yet pulling hard enough to cause visible structural changes on OCT imaging, and symptoms may be absent. Traction means the attachment is creating measurable distortion, swelling, or structural damage in the macula. This distinction is clinically important because adhesion alone is typically monitored, while traction may call for intervention depending on how symptoms are progressing.
Pars plana vitrectomy is a well-established procedure with a strong record of success for releasing VMT and improving visual acuity. As with any surgery, there are risks to discuss with your retina specialist, including infection, bleeding, cataract development, and in rare cases, retinal detachment. Your specialist will review your individual situation to help you weigh the benefits against the risks before making any decisions. For many patients, especially those with a macular hole or worsening symptoms, the benefits of surgery outweigh the risks.
Not necessarily, but it is possible. Because the vitreous changes that lead to VMT are age-related and occur in both eyes, the second eye may develop the condition over time. This is one reason our specialists monitor both eyes at follow-up visits, even when only one eye is currently affected. Early detection in the second eye, before significant traction develops, can allow for a wider range of treatment options and better outcomes.
Recovery from an intravitreal ocriplasmin injection is generally quick. Most patients resume normal activities within a day or two, though some temporary visual side effects such as floaters or blurring may persist for a short time. Recovery from vitrectomy surgery takes considerably longer, often several weeks, and may involve positional restrictions and activity limitations if a gas bubble is used. Your specialist will give you specific instructions based on what was done during your procedure and the details of your individual case.
Schedule a Visit With Our Team
Our retina specialists are dedicated to providing personalized, expert care for patients with vitreomacular traction and related conditions. Whether you are newly diagnosed, monitoring a known condition, or experiencing new symptoms, we are here to guide you at every step. We encourage you to schedule an appointment so we can evaluate your vision, answer your questions, and work with you on a treatment plan that fits your needs.